Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
about
Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expressionGenomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesTAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulationSequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activationRole of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeatRegulation of human immunodeficiency virus env expression by the rev gene productVisna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirusHuman immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cellsSubcellular localization of the human immunodeficiency virus trans-acting art gene productInduction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinasesIdentification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to functionIn vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factorMutational analysis of the conserved basic domain of human immunodeficiency virus tat proteinStructural and functional characterization of human immunodeficiency virus tat proteinLentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactorrev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNAThe Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKRAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsProduction of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular cloneEpstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virusHuman herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancerTrans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.Transactivation of a ribosomal gene by simian virus 40 large-T antigen requires at least three activities of the protein.Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface.Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genomeTwo cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I.A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.HIV persistence: chemokines and their signalling pathways.Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1.Human immunodeficiency virus type 1 negative factor is a transcriptional silencer.
P2860
Q22253171-6FF06493-9468-4D30-B273-CEB7F788DBC4Q24310870-8B2BCDE0-9B27-4EAC-B54B-E92706F0CC6CQ24319734-029C3C22-F2A6-42D5-B1B9-810DFFD36521Q24523183-4DAB7B7A-BF04-417B-9CD0-23017FC682D9Q24537527-4AEC169C-283B-46AF-966D-6344A84076FFQ24555668-435BE6B7-8BA4-488E-A039-77E481AE5946Q24645645-C1E40404-B4A8-4944-AC66-DFD2E76C5095Q24645992-B551649A-8B4E-4C28-A51C-4024386B141DQ24646216-0BADDC57-A258-46FA-89CB-06E2F8C6330BQ24648639-22B6BA41-6419-4732-9BA3-26F4E2C5DC65Q24649124-0FBE81E4-1952-40DE-B789-AEA3C793030FQ24651489-70A2A9CE-AF84-4F30-9AD1-F3D6522D6885Q24651825-B8A73754-2B55-4D82-B6CB-D2DE2AF4CF4DQ24652587-FC25F6C5-C693-42EF-A03D-760BA12ABD79Q24655901-8E468082-5223-4DD7-BD98-8E017F9CE06BQ24656004-4313ED3B-4A99-4E69-84B1-9C5317BADAECQ24656163-E2490E21-A249-4A55-B887-8483A743BFDBQ24676286-2827526E-AFF0-4E7C-B14F-5D89C32987A7Q28279513-550396BA-4CA9-44F6-BF7E-96EA58867C81Q28306498-01244DA9-2ED2-4526-8307-170ED7AC4DAAQ28378840-4F419A9C-0087-489C-81D8-13A151A65A5AQ29547734-48331176-17D1-493A-B655-742950BD7CCAQ30452167-0CFCC558-936C-4908-852F-40C694D1EC8FQ33192810-C5FEC4A0-6FDF-41DC-A2F7-5236D8628E54Q33558271-2774B9F1-197A-4DFC-9C05-834C64D4CB13Q33562331-A4671590-B1B4-4EA0-BE91-0A70AB845114Q33581303-CB336A81-9FE7-4C00-9B58-F73C50FFBCD5Q33634797-6E2C4F82-28C6-44D4-B8DA-5017B1C4B606Q33639062-E5DB1FBC-E65B-4AF8-AA2A-BD000EC8E3CAQ33643113-FAADC018-5076-43B9-A869-2CE4BBA8582CQ33649232-351DACAC-E712-440D-A73C-BBAAA156ECA9Q33650651-F026ABDD-375D-49C1-B147-6F35AF3A6781Q33662926-D9C354AA-6B88-4260-86BD-7708B67125C7Q33684251-2B05A670-81B0-45DD-A285-2E257EA07A18Q33774665-197FDC73-F3B6-4E43-8C11-AE0152D08672Q33783417-9B300508-D6E5-4D88-9266-3D0A44184BEEQ33787595-DE101BB3-B844-4A6C-AC70-DBAA47812168Q33797102-CE5CF6E6-A29A-4AB5-B2AE-F336A238B968Q33815010-9CFF6B99-31C3-40A1-A4F9-2FC7FC086581Q33836630-572D19D1-68E9-40A9-A90A-119B92F1F69B
P2860
Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Location of the trans-activati ...... l lymphotropic virus type III.
@ast
Location of the trans-activati ...... l lymphotropic virus type III.
@en
Location of the trans-activati ...... l lymphotropic virus type III.
@nl
type
label
Location of the trans-activati ...... l lymphotropic virus type III.
@ast
Location of the trans-activati ...... l lymphotropic virus type III.
@en
Location of the trans-activati ...... l lymphotropic virus type III.
@nl
prefLabel
Location of the trans-activati ...... l lymphotropic virus type III.
@ast
Location of the trans-activati ...... l lymphotropic virus type III.
@en
Location of the trans-activati ...... l lymphotropic virus type III.
@nl
P2093
P356
P1433
P1476
Location of the trans-activati ...... l lymphotropic virus type III.
@en
P2093
Haseltine W
Wong-Staal F
P356
10.1126/SCIENCE.2990041
P407
P577
1985-07-01T00:00:00Z